SCHEMBL25016295

SCHEMBL25016295

CC(C)(C)OC(=O)NC(=N)c1ccc2cc(C(=O)N3CC[C@@H](NC(=O)OC(C)(C)C)C3)n(Cc3cccc4ccccc34)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 2/20 0.41
▸ PADI4 Q9UM07 4/20 0.40
▸ PARP1 P09874 1/20 0.40
▸ NAMPT P43490 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ ADORA2A P29274 5/20 0.37
▸ ADORA2B P29275 4/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ DPP4 P27487 1/20 0.36
▸ KDM4D Q6B0I6 1/20 0.36
▸ HDAC3 O15379 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016100 1.00 USP30 (0.41) USP30PADI4PARP1NAMPTCYP1A2
SCHEMBL25015970 0.91 CYP3A4 (0.38) USP30PADI4CYP1A2CYP3A4CYP2C9
SCHEMBL25015739 0.91 CYP3A4 (0.38) USP30PADI4CYP1A2CYP3A4CYP2C9
SCHEMBL25016101 0.88 HTR2C (0.44) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL28583314 0.87 USP30 (0.46) USP30PARP1
SCHEMBL25015964 0.86 CNR2 (0.39) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL25016862 0.86 USP30 (0.49) USP30PADI4PARP1
SCHEMBL25017554 0.86 USP30 (0.49) USP30PADI4PARP1
SCHEMBL25017557 0.85 KDM4E (0.44) USP30SMN1; SMN2
SCHEMBL30180863 0.85 EPHX1 (0.36) MCL1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 USP30 2653/4885PADI4 1239/4885PARP1 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback